Curation
PascalFrancis
Racine
Curation
Checkpoint
PascalFrancis
Racine
PascalFrancis
Exploration
Accueil
Racine
Racine

La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Dopamine D2 receptor density remains constant in treated Parkinson's disease

Identifieur interne : 000C61 ( PascalFrancis/Curation ); précédent : 000C60; suivant : 000C62

Dopamine D2 receptor density remains constant in treated Parkinson's disease

Auteurs : M. Guttman ; P. Seeman ; G. P. Reynolds ; P. Riederer ; K. Jellinger ; W. W. Tourtellotte

Source :

RBID : Pascal:87-0253441

Descripteurs français

English descriptors

pA  
A01 01  1    @0 0364-5134
A03   1    @0 Ann. neurol.
A05       @2 19
A06       @2 5
A08 01  1  ENG  @1 Dopamine D2 receptor density remains constant in treated Parkinson's disease
A11 01  1    @1 GUTTMAN (M.)
A11 02  1    @1 SEEMAN (P.)
A11 03  1    @1 REYNOLDS (G. P.)
A11 04  1    @1 RIEDERER (P.)
A11 05  1    @1 JELLINGER (K.)
A11 06  1    @1 TOURTELLOTTE (W. W.)
A14 01      @1 Univ. Toronto, fac. medicine, dep. medicine @2 Toronto ON M5S 1A8 @3 CAN @Z A11011000
A20       @1 487-492
A21       @1 1986
A23 01      @0 ENG
A43 01      @1 CNRS @2 16555
A44       @0 9900
A45       @0 41 ref.
A47 01  1    @0 87-0253441
A60       @1 P
A61       @0 A
A64   1    @0 Annals of neurology
A66 01      @0 USA
C02 01  2    @0 002B02B06
C03 01  2  FRE  @0 Parkinson maladie
C03 02  2  FRE  @0 Chimiothérapie
C03 03  2  FRE  @0 Lévodopa
C03 04  2  FRE  @0 Récepteur dopaminergique D2
C03 05  2  FRE  @0 Encéphale
C03 06  2  FRE  @0 Putamen
C03 07  2  FRE  @0 Noyau caudé
C03 08  2  FRE  @0 Homme
C03 09  2  FRE  @0 Age
C03 10  2  FRE  @0 Numération
C03 01  2  ENG  @0 Parkinson disease
C03 02  2  ENG  @0 Chemotherapy
C03 03  2  ENG  @0 Levodopa
C03 04  2  ENG  @0 Dopaminergic receptor D2
C03 05  2  ENG  @0 Brain (Vertebrata)
C03 06  2  ENG  @0 Putamen
C03 07  2  ENG  @0 Caudate nucleus
C03 08  2  ENG  @0 Human
C03 09  2  ENG  @0 Age
C03 10  2  ENG  @0 Numeration
C03 01  2  SPA  @0 Parkinson enfermedad
C03 02  2  SPA  @0 Quimioterapia
C03 03  2  SPA  @0 Levodopa
C03 04  2  SPA  @0 Receptor dopaminérgico D2
C03 05  2  SPA  @0 Encefalo
C03 06  2  SPA  @0 Putamen
C03 07  2  SPA  @0 Nucleo caudado
C03 08  2  SPA  @0 Hombre
C03 09  2  SPA  @0 Edad
C03 10  2  SPA  @0 Numeracion
N21       @1 627
N82       @1 NBS

Links toward previous steps (curation, corpus...)

Links to Exploration step

Pascal:87-0253441

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Dopamine D
<sub>2</sub>
receptor density remains constant in treated Parkinson's disease</title>
<author>
<name sortKey="Guttman, M" sort="Guttman, M" uniqKey="Guttman M" first="M." last="Guttman">M. Guttman</name>
</author>
<author>
<name sortKey="Seeman, P" sort="Seeman, P" uniqKey="Seeman P" first="P." last="Seeman">P. Seeman</name>
</author>
<author>
<name sortKey="Reynolds, G P" sort="Reynolds, G P" uniqKey="Reynolds G" first="G. P." last="Reynolds">G. P. Reynolds</name>
</author>
<author>
<name sortKey="Riederer, P" sort="Riederer, P" uniqKey="Riederer P" first="P." last="Riederer">P. Riederer</name>
</author>
<author>
<name sortKey="Jellinger, K" sort="Jellinger, K" uniqKey="Jellinger K" first="K." last="Jellinger">K. Jellinger</name>
</author>
<author>
<name sortKey="Tourtellotte, W W" sort="Tourtellotte, W W" uniqKey="Tourtellotte W" first="W. W." last="Tourtellotte">W. W. Tourtellotte</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">87-0253441</idno>
<date when="1986">1986</date>
<idno type="stanalyst">PASCAL 87-0253441 INIST</idno>
<idno type="RBID">Pascal:87-0253441</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001266</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000C61</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Dopamine D
<sub>2</sub>
receptor density remains constant in treated Parkinson's disease</title>
<author>
<name sortKey="Guttman, M" sort="Guttman, M" uniqKey="Guttman M" first="M." last="Guttman">M. Guttman</name>
</author>
<author>
<name sortKey="Seeman, P" sort="Seeman, P" uniqKey="Seeman P" first="P." last="Seeman">P. Seeman</name>
</author>
<author>
<name sortKey="Reynolds, G P" sort="Reynolds, G P" uniqKey="Reynolds G" first="G. P." last="Reynolds">G. P. Reynolds</name>
</author>
<author>
<name sortKey="Riederer, P" sort="Riederer, P" uniqKey="Riederer P" first="P." last="Riederer">P. Riederer</name>
</author>
<author>
<name sortKey="Jellinger, K" sort="Jellinger, K" uniqKey="Jellinger K" first="K." last="Jellinger">K. Jellinger</name>
</author>
<author>
<name sortKey="Tourtellotte, W W" sort="Tourtellotte, W W" uniqKey="Tourtellotte W" first="W. W." last="Tourtellotte">W. W. Tourtellotte</name>
</author>
</analytic>
<series>
<title level="j" type="main">Annals of neurology</title>
<title level="j" type="abbreviated">Ann. neurol.</title>
<idno type="ISSN">0364-5134</idno>
<imprint>
<date when="1986">1986</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Annals of neurology</title>
<title level="j" type="abbreviated">Ann. neurol.</title>
<idno type="ISSN">0364-5134</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Age</term>
<term>Brain (Vertebrata)</term>
<term>Caudate nucleus</term>
<term>Chemotherapy</term>
<term>Dopaminergic receptor D2</term>
<term>Human</term>
<term>Levodopa</term>
<term>Numeration</term>
<term>Parkinson disease</term>
<term>Putamen</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Parkinson maladie</term>
<term>Chimiothérapie</term>
<term>Lévodopa</term>
<term>Récepteur dopaminergique D2</term>
<term>Encéphale</term>
<term>Putamen</term>
<term>Noyau caudé</term>
<term>Homme</term>
<term>Age</term>
<term>Numération</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0364-5134</s0>
</fA01>
<fA03 i2="1">
<s0>Ann. neurol.</s0>
</fA03>
<fA05>
<s2>19</s2>
</fA05>
<fA06>
<s2>5</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Dopamine D
<sub>2</sub>
receptor density remains constant in treated Parkinson's disease</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>GUTTMAN (M.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>SEEMAN (P.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>REYNOLDS (G. P.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>RIEDERER (P.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>JELLINGER (K.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>TOURTELLOTTE (W. W.)</s1>
</fA11>
<fA14 i1="01">
<s1>Univ. Toronto, fac. medicine, dep. medicine</s1>
<s2>Toronto ON M5S 1A8</s2>
<s3>CAN</s3>
<sZ>A11011000</sZ>
</fA14>
<fA20>
<s1>487-492</s1>
</fA20>
<fA21>
<s1>1986</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>CNRS</s1>
<s2>16555</s2>
</fA43>
<fA44>
<s0>9900</s0>
</fA44>
<fA45>
<s0>41 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>87-0253441</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i2="1">
<s0>Annals of neurology</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC02 i1="01" i2="2">
<s0>002B02B06</s0>
</fC02>
<fC03 i1="01" i2="2" l="FRE">
<s0>Parkinson maladie</s0>
</fC03>
<fC03 i1="02" i2="2" l="FRE">
<s0>Chimiothérapie</s0>
</fC03>
<fC03 i1="03" i2="2" l="FRE">
<s0>Lévodopa</s0>
</fC03>
<fC03 i1="04" i2="2" l="FRE">
<s0>Récepteur dopaminergique D2</s0>
</fC03>
<fC03 i1="05" i2="2" l="FRE">
<s0>Encéphale</s0>
</fC03>
<fC03 i1="06" i2="2" l="FRE">
<s0>Putamen</s0>
</fC03>
<fC03 i1="07" i2="2" l="FRE">
<s0>Noyau caudé</s0>
</fC03>
<fC03 i1="08" i2="2" l="FRE">
<s0>Homme</s0>
</fC03>
<fC03 i1="09" i2="2" l="FRE">
<s0>Age</s0>
</fC03>
<fC03 i1="10" i2="2" l="FRE">
<s0>Numération</s0>
</fC03>
<fC03 i1="01" i2="2" l="ENG">
<s0>Parkinson disease</s0>
</fC03>
<fC03 i1="02" i2="2" l="ENG">
<s0>Chemotherapy</s0>
</fC03>
<fC03 i1="03" i2="2" l="ENG">
<s0>Levodopa</s0>
</fC03>
<fC03 i1="04" i2="2" l="ENG">
<s0>Dopaminergic receptor D2</s0>
</fC03>
<fC03 i1="05" i2="2" l="ENG">
<s0>Brain (Vertebrata)</s0>
</fC03>
<fC03 i1="06" i2="2" l="ENG">
<s0>Putamen</s0>
</fC03>
<fC03 i1="07" i2="2" l="ENG">
<s0>Caudate nucleus</s0>
</fC03>
<fC03 i1="08" i2="2" l="ENG">
<s0>Human</s0>
</fC03>
<fC03 i1="09" i2="2" l="ENG">
<s0>Age</s0>
</fC03>
<fC03 i1="10" i2="2" l="ENG">
<s0>Numeration</s0>
</fC03>
<fC03 i1="01" i2="2" l="SPA">
<s0>Parkinson enfermedad</s0>
</fC03>
<fC03 i1="02" i2="2" l="SPA">
<s0>Quimioterapia</s0>
</fC03>
<fC03 i1="03" i2="2" l="SPA">
<s0>Levodopa</s0>
</fC03>
<fC03 i1="04" i2="2" l="SPA">
<s0>Receptor dopaminérgico D2</s0>
</fC03>
<fC03 i1="05" i2="2" l="SPA">
<s0>Encefalo</s0>
</fC03>
<fC03 i1="06" i2="2" l="SPA">
<s0>Putamen</s0>
</fC03>
<fC03 i1="07" i2="2" l="SPA">
<s0>Nucleo caudado</s0>
</fC03>
<fC03 i1="08" i2="2" l="SPA">
<s0>Hombre</s0>
</fC03>
<fC03 i1="09" i2="2" l="SPA">
<s0>Edad</s0>
</fC03>
<fC03 i1="10" i2="2" l="SPA">
<s0>Numeracion</s0>
</fC03>
<fN21>
<s1>627</s1>
</fN21>
<fN82>
<s1>NBS</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C61 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000C61 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:87-0253441
   |texte=   Dopamine D2 receptor density remains constant in treated Parkinson's disease
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022